Lifecore Biomedical (LFCR) Tops Q2 EPS by 4c

Lifecore Biomedical (NASDAQ: LFCR) reported Q2 EPS of ($0.19), $0.04 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $34.17 million versus the consensus estimate of $31.66 million.

For earnings history and earnings-related data on Lifecore Biomedical (LFCR) click here.

You May Also Be Interested In

• SpaceX tumbles amid AI spending concerns; Musk outlines $1 trillion revenue target
• Global Indemnity (GBLI) Misses Q2 EPS by 17c
• National Retail Properties (NNN) Tops Q2 EPS by 1c; Offers Guidance